Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cashin-Hemphill

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The American Journal of Cardiology|February 25, 1993
Femoral and coronary angiographic trialsL Cashin-Hemphill
Current Opinion in Lipidology|February 19, 2000
Non-pharmacological lowering of low-density lipoprotein by apheresis and surgical techniquesR S Lees, L Cashin-Hemphill, A M Lees
The American Journal of Cardiology|November 14, 2000
Low-density lipoprotein apheresis therapy during pregnancyL Cashin-Hemphill, M Noone, J F Abbott, et al.
The American Journal of Cardiology|March 12, 1999
Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event TrialL Cashin-Hemphill, G Holmvang, R C Chan, et al.
JAMA|June 19, 1987
Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass graftsD H Blankenhorn, S A Nessim, R L Johnson, et al.
JAMA|December 19, 1990
Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-upL Cashin-Hemphill, W J Mack, J M Pogoda, et al.
JAMA|June 21, 1995
Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosisH N Hodis, W J Mack, L LaBree, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|March 1, 1991
Evaluation of human panelists in assessing coronary atherosclerosisS P Azen, L Cashin-Hemphill, J Pogoda, et al.
Annals of Internal Medicine|September 1, 1987
Alterations in serum thyroid hormonal indices with colestipol-niacin therapyL Cashin-Hemphill, C A Spencer, J T Nicoloff, et al.
Circulation|January 1, 1996
Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis StudyS P Azen, W J Mack, L Cashin-Hemphill, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The American Journal of Cardiology|February 25, 1993
Femoral and coronary angiographic trialsL Cashin-Hemphill
Current Opinion in Lipidology|February 19, 2000
Non-pharmacological lowering of low-density lipoprotein by apheresis and surgical techniquesR S Lees, L Cashin-Hemphill, A M Lees
The American Journal of Cardiology|November 14, 2000
Low-density lipoprotein apheresis therapy during pregnancyL Cashin-Hemphill, M Noone, J F Abbott, et al.
The American Journal of Cardiology|March 12, 1999
Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event TrialL Cashin-Hemphill, G Holmvang, R C Chan, et al.
JAMA|June 19, 1987
Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass graftsD H Blankenhorn, S A Nessim, R L Johnson, et al.
JAMA|December 19, 1990
Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-upL Cashin-Hemphill, W J Mack, J M Pogoda, et al.
JAMA|June 21, 1995
Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosisH N Hodis, W J Mack, L LaBree, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|March 1, 1991
Evaluation of human panelists in assessing coronary atherosclerosisS P Azen, L Cashin-Hemphill, J Pogoda, et al.
Annals of Internal Medicine|September 1, 1987
Alterations in serum thyroid hormonal indices with colestipol-niacin therapyL Cashin-Hemphill, C A Spencer, J T Nicoloff, et al.
Circulation|January 1, 1996
Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis StudyS P Azen, W J Mack, L Cashin-Hemphill, et al.
Pageof 2